AAAdejare (Jay) Atanda

Adejare (Jay) Atanda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adejare (Jay) Atanda has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Access to routine primary healthcare and past-year dental visits: results from the 2017–2020 National Health and Nutrition Examination Survey

    by Seana Camp, McKing Izeiza Amedari, Adejare (Jay) Atanda

    Aim: To examine the relationship between access to routine primary healthcare (PHC) and receipt of dental visits. Background: PHC plays a vital role in promoting overall health and connecting patients to preventive services. Regular dental visits are crucial for preventing oral health issues and managing chronic diseases associated with oral health. However, disparities in healthcare access may influence the likelihood of individuals receiving necessary dental care. Methods: Data from 8, 727 participants ≥ 20 years in the 2017–2020 National Health and Nutritional Examination Survey were used for cross-sectional analysis. Logistic regressions explored the relationship between PHC and ‘past-year dental visits’, while controlling for sociodemographics. Findings: 84% of the study population had access to routine PHC, and 63% had a past-year dental visit. Adults with PHC were significantly more likely to have had a past-year dental visit (OR = 2.24; 95% CI: 1.76–2.84). This was true for women, the oldest adult age group, and those with the highest educational levels. Black study participants were less likely to have had a past-year dental visit (OR = 0.55; 95% CI: 0.54, 0.83), so were the unmarried and those without health insurance. Conclusion: Access to routine PHC significantly increases the likelihood of a past-year dental visit, with gender, age, and educational levels having strongest effects. However, Black adults remain less likely to utilize dental services, even with access to routine PHC and health insurance. Strengthening the physician-dentist patient partnership through integrated delivery models of care that embed oral health services with primary care could be key.

  • Open Access

    Living Framework and Guidelines for Information Disclosure in Biosecurity

    by Adejare (Jay) Atanda, Matthew Nicotra, Benjamin Sperisen, Elika Somani, Henry Willis

    Advances in biological research can produce powerful insights with broad public benefits – but can also generate information that, if misused, poses serious biosecurity risks. Yet institutions lack clear, actionable guidance on how to assess and respond to such risks without stifling innovation or scientific discovery.In response, the Meselson Center at RAND has developed a living framework and toolkit to support responsible decisions about the disclosure of potentially hazardous biosecurity information. This framework is grounded in the principle that researchers and institutions must balance the societal benefits of open science with the real and growing risks of misuse of potentially dangerous information. It also provides a structured process for identifying when and how to pause, limit, or modify the release of sensitive research findings. Importantly, the framework is designed to be simple, transparent, actionable, improvable, and repeatable – capable of evolving as technologies change and our understanding of risk matures.For this working paper, we used a conceptual framing to systematically explore the trade-offs in biosecurity information disclosure, enabling us to identify the key questions that should guide decision-making. To do this, we reviewed published academic work, government and independent research organization reports, and working papers posted on open science repositories. This was followed by engagement with RAND experts with expertise in biology, artificial intelligence, information security, risk analysis, security analysis, and red teaming to answer the following questions:· How should the Meselson Center decide whether to publish potentially hazardous information that it generates through biosecurity research efforts?· What key factors and incentives that shape strategies for managing biosecurity information hazards?This project aimed to make our understanding of the tradeoffs between disclosure and non-disclosure significantly more concrete and produce a set of non-exhaustive mitigation actions. Ultimately, this framework is intended to be a living document, evolving as science, policy, and threats change. It aims to reduce biosecurity risks without stifling scientific inquiry, providing a robust and adaptable model that other institutions can build on when seeking to manage theinformation hazard dilemma in a rapidly advancing research landscape. By embedding oversight, promoting transparency, and grounding evaluations in a structured methodology, the framework and toolkit provides a foundation for making difficult disclosure decisions in a principled and practical way.

  • Loper-Proofing Next-Generation Biosecurity Policy

    by Shane Reader, Adejare Jay Atanda

    Chevron Deference, recognizing that Congress often drafts statutes broadly, allowed administrative agencies to use their expertise to make policy decisions within those boundaries. Considered settled law for 40 years, this principle played a pivotal role in federal court rulings. However, the decision in Loper-Bright Enterprises v. Raimondo reversed this precedent, creating significant ramifications for biosecurity regulations, including in the domains of public health, biotechnology, and the bioeconomy. After an additional ruling loosened limitations on when suits may be filed, dissatisfied individuals or organizations are enfranchised to contest settled agency decisions without the protection of Chevron. At the heart of Loper-Bright lies the question: how much influence should subject-matter experts hold over the interpretation of ambiguous laws? This article examines the potential ripple effects of overturning Chevron, focusing on the impact on biosecurity and the bioeconomy, while offering recommendations to advance meaningful policy in the Congressional, Executive, and Judicial branches after Loper-Bright.


  • Ending water fluoridation will threaten warfighter health

    by Adejare (Jay) Atanda

    The military has long recognised the importance of dental health, turning away potential recruits1 who did not have six opposing upper and lower front teeth2 to bite off the end of the tough paper powder cartridges of civil war era weapons. Before the war began, Surgeon Charles Tripler declared ‘loss of incisor and canine teeth of both jaws’ disqualifying,3 and by 1914, it was necessary to have a sufficient number of sound teeth for efficient mastication for recruitment.4

  • Open Access

    Medicaid expansion, dental visits and expenditures in veterans, older adults, and the foreign-born

    by Adejare Atanda, McKing I. Amedari, Israel T. Agaku, Lenwood W. Hayman, Mian B. Hossain

    We assessed the relationship between implementation of the Patient Protection and Affordable Care Act (ACA), indicated as a state expanding Medicaid, dental visits, and costs in U.S. military veterans, older adults ≥ 65 years, and foreign-born individuals. Using the 2012–2016 Medical Expenditure Panel Surveys for a secondary data analysis, logistic and two-part regressions were used to model dental visits and costs as a function of key explanatory variables. Differences-in-differences estimates compared changes in dental visits and costs in Medicaid expansion to non- expansion states. Post-Medicaid expansion and ACA implementation, the foreign-born in Medicaid expansion states had higher odds of a dental visit compared to those in non-Medicaid expansion states (OR = 1.17, 95% CI, 1.05–1.32) in adjusted analysis. While they spent $31 more than the predicted per capita expenditure of $395, this increase was not statistically significant. The changes in dental visits and expenditures for veterans and older adults ≥ 65 years were not statistically significant. These findings suggest that the ACA, through expansion of Medicaid programs has improved access for the foreign-born while controlling costs. Health care reform initiatives like Medicaid expansion can enhance access to dental care and help mitigate the economic and access to care barriers vulnerable population groups like the foreign-born face.


  • Open Access

    Changes in dental visits and expenditures in veterans, older adults, and foreign-born after affordable care act repeal efforts: A quasi-experimental difference-in-differences study

    by Adejare J. Atanda, Israel T. Agaku, Lenwood W. Hayman, Mian B. Hossain

    Introduction: The Patient Protection and Affordable Care Act (ACA) faced political and legal challenges before and after enactment, and through implementation, including serious attempts at repealing and dismantling its main provisions in 2017. We assessed the relationship between ACA...


  • Top Cited Papers
    Open Access

    Tooth retention, health, and quality of life in older adults: a scoping review

    by Adejare Jay Atanda, Alicia A. Livinski, Steven D. London, Shahdokht Boroumand, Darien Weatherspoon, Timothy J. Iafolla, Bruce A. Dye

    Objective: This scoping review describes the relationship between tooth retention, health, and quality of life in older adults. Methods: Seven databases were searched for English language articles for subjects ≥ 65 y from 1981 to 2021. Exposure was tooth retention (≥ 20), and outcomes were general/systemic health and quality of life. Methodological quality was assessed using the Newcastle–Ottawa Scale and Cochrane Risk of Bias 2.0 tool. Results: 140 articles were included, only four were randomized trials. Inter-rater agreement (κ) regarding study inclusion was 0.924. Most were assessed with low risk of bias (n = 103) and of good quality (n = 96). Most studies were conducted in Japan (n = 60) and Europe (n = 51) and only nine in the US. Tooth retention was referred to as “functional dentition” in 132 studies and “shortened dental arch” in 19 studies. Study outcomes were broadly synthesized as (1) cognitive decline/functional dependence, (2) health status/chronic diseases, (3) nutrition, and (4) quality of life. Discussion: There is a positive relationship between tooth retention, overall health, and quality of life. Older adults retaining ≥ 20 teeth are less likely to experience poorer health. Having < 20 teeth increases the likelihood for functional dependence and onset of disability, and may affect successful ageing. This review supports the general finding that the more teeth older adults retain as they age, the less likely they are to have adverse health outcomes. However, significant knowledge gaps remain which can limit decision-making affecting successful ageing for many older adults. This review highlights the need to consider, as an important marker of oral health and function, the retention of a functional minimum of a natural dentition, rather than a simple numeric score of missing teeth.


  • Open Access

    Epidemiological and Clinical Characteristics of COVID-19 Patients with Cancers: A Systematic Review and Meta-Analysis of Global Data

    by Xiangyi Kong, Yihang Qi, Junjie Huang, Yang Zhao, Yongle Zhan, Xuzhen Qin, Zhihong Qi, Adejare (Jay) Atanda, Lei Zhang, Jing Wang, et al.

    Summary: Background Data on the prevalence of cancer in coronavirus disease 2019 (COVID-19)-infected patients and the severe illness incidence and mortality of COVID-19 patients with cancers remains unclear. Methods: We systematically searched PubMed, Embase, Cochrane Library, and Web of Science, from database inception to July 15, 2020, for studies of patients with COVID-19 infection that had available comorbidity information on cancer. The primary endpoint was the pooled prevalence of cancer in COVID-19 patients and the secondary endpoint was the outcomes of COVID-19-infected cancer patients with incidence of severe illness and death rate. We calculated the pooled prevalence and corresponding 95% confidence intervals (95% CIs) using a random-effects model, and performed meta-regression analyses to explore heterogeneity. Subgroup analyses were conducted based on continent, country, age, sample size and study design. Findings: A total of 107 eligible global studies were included in the systematic review. 90 studies with 94,845 COVID-19 patients in which 4,106 patients with cancer morbidity were included in the meta-analysis for prevalence of cancer morbidity among COVID-19 patients. 21 studies with 70,969 COVID-19 patients in which 3,351 patients with cancer morbidity who had severe illness or death during the studies. The overall prevalence of cancer among the COVID-19 patients was 0.07 (95% CI 0.05∽0.09). The cancer prevalence in COVID-19 patients of Europe (0.22, 95% CI 0.17∽0.28) was higher than that in Asia Pacific (0.04, 95% CI 0.03∽0.06) and North America (0.05, 95% CI 0.04∽0.06). The prevalence of COVID-19-infected cancer patients over 60 years old was 0.10 (95% CI 0.07∽0.14), higher than that of patients equal and less than 60 years old (0.05, 95% CI 0.03∽0.06). The pooled prevalence of severe illness among COVID-19 patients with cancers was 0.35 (95% CI 0.27∽0.43) and the pooled death rate of COVID-19 patients with cancers was 0.18 (95% CI 0.14∽0.18). The pooled incidence of severe illness of COVID-19 patients with cancers from Asia Pacific, Europe, and North America were 0.38(0.24, 0.52), 0.36(0.17, 0.55), and 0.26(0.20, 0.31), respectively; and the pooled death rate from Asia Pacific, Europe, and North America were 0.17(0.10, 0.24), 0.26(0.13, 0.39), and 0.19(0.13, 0.25), respectively. Interpretation: To our knowledge, this study is the most comprehensive and up-to-date metaanalysis assessing the prevalence of cancer among COVID-19 patients, severe illness incidence and mortality rate. The prevalence of cancer varied significantly in geographical continents and age. The COVID-19 patients with cancer were at-risk for severe illness and a high death rate. The European COVID-19 patients had the highest cancer prevalence among the three continents examined and were also the most likely to progress to severe illness and death. Although the Asia Pacific COVID-19 patients had the lowest cancer prevalence, their severe illness rate was similar to that of European’s. Research in context: Evidence before this study: Coronavirus disease (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a newly discovered coronavirus, which leads to respiratory illness and can be transmitted from person to person. As the infection has become widespread, concern for the influence of COVID-19 on patients with cancer has grown. Previous studies suggest that patients with a history of active malignancy might be at increased risk for COVID-19, developing COVID-19-related complications and having a poorer prognosis. Until now, however, few studies explored the following two questions: 1) what is the estimated prevalence of cancer patients with COVID-19 infection; and 2) do COVID-19-infected cancer-patients have distinct clinical courses and worse outcomes compared with COVID-19-infected patients without cancers. The latter is based on the former to further explore the characteristics of clinical outcomes of such patients. The clarification of these two questions will greatly help to understand the relationship between COVID-19 and cancer in terms of clinical epidemiology, and thus facilitate the formulation of targeted and relevant public health policies. Added value of this study: To our knowledge, this systematic review and meta-analysis of 107 studies is the most comprehensive and up-to-date assessing the prevalence of cancer among COVID-19 patients, the incidence of severe illness and mortality rate of COVID-19 patients with cancers. We provided a relatively accurate overall cancer prevalence among the all COVID-19 patients (7%), stratified by geographical continent, country, age, study sample size, and study design type. We also presented the pooled severe illness and mortality rates stratified by continent. European COVID-19-infected cancer patients seemed the most likely to both develop cancer and progress to severe illness and death. Implications of all the available evidence: Our findings have reinforced important considerations of clinical care and emphasized the urgent unmet needs for COVID-19 patients with cancers using the pooled prevalence, incidence of severe illness, and death rates as evidence. Also, after comparing the cancer prevalence, incidence of severe illness, and death rate of COVID-19 patients from different continents, European population may require stronger control measures than the Asia Pacific and North American populations. In the future, as more data will be available, it will be interesting to further investigate the differences of sociodemographic and climcopathological features between COVID-19-infected patients with cancer and without cancer.

  • Open Access

    Association between blood circulating vitamin D and colorectal cancer risk in Asian countries: a systematic review and dose-response meta-analysis

    by Lin Zhang, Huachun Zou, Yang Zhao, Chunlei Hu, Adejare Atanda, Xuzhen Qin, Peng Jia, Yu Jiang, Zhihong Qi

    Objectives: To assess the association between blood circulating vitamin D levels and colorectal cancer risk in the Asian population.Design: This is a systematic review and dose-response meta-analysis of observational studies that investigated the relationship between blood circulating vitamin D levels and colorectal cancer risk in the Asian population.Data sources: Relevant studies were identified through a literature search in Medline, Embase and Web of Science from 1st January 1980 to 31st January 2019. Eligibility criteria: original studies published in peer-reviewed journals investigating the association between blood circulating vitamin D levels and the risk of colorectal cancer and/or adenoma in Asian countries.Data extraction and synthesis: Two authors independently extracted data and assessed the quality of included studies. Study-specific ORs were pooled using a random-effects model. A dose-response meta-analysis was performed with generalised least squares regression. We applied the Newcastle-Ottawa Scale quality assessment to evaluate the quality of the selected studies.Results: The eight included studies encompassed a total of 2916 cases and 6678 controls. The pooled ORs of colorectal cancer for the highest versus lowest categories of blood circulating vitamin D levels was 0.75 (95% CI 0.58 to 0.97) up to 36.5 ng/mL in the Asian population. There was heterogeneity among the studies (I2=53.9%,Pheterogeneity=0.034). The dose-response meta-analysis indicated a significant linear relationship (Pnon-linearity=0.11). An increment of 16 ng/mL in blood circulating vitamin D level corresponded to an OR of 0.79 (95% CI 0.64 to 0.97).Conclusions: The results of this meta‐analysis indicate that blood circulating vitamin D level is associated with decreased risk of colorectal cancer in Asian countries. The dose-response meta-analysis shows that the strength of this association among the Asian population is similar to that among the Western population. Our study suggests that the Asian population should improve nutritional status and maintain a higher level of blood circulating vitamin D.